Stephen F. Betz - Net Worth and Insider Trading
Stephen F. Betz Net Worth
The estimated net worth of Stephen F. Betz is at least $4 Million dollars as of 2024-11-05. Stephen F. Betz is the Chief Scientific Officer of Crinetics Pharmaceuticals Inc and owns about 68,576 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $4 Million. Details can be seen in Stephen F. Betz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen F. Betz has not made any transactions after 2024-09-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen F. Betz
Stephen F. Betz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen F. Betz owns 1 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) .
Click here to see the complete history of Stephen F. Betz’s form 4 insider trades.
Insider Ownership Summary of Stephen F. Betz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | 2024-09-10 | Chief Scientific Officer |
Stephen F. Betz Latest Holdings Summary
Stephen F. Betz currently owns a total of 1 stock. Stephen F. Betz owns 68,576 shares of Crinetics Pharmaceuticals Inc (CRNX) as of September 10, 2024, with a value of $4 Million.
Latest Holdings of Stephen F. Betz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | 2024-09-10 | 68,576 | 56.88 | 3,900,260 |
Holding Weightings of Stephen F. Betz
Stephen F. Betz Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen F. Betz has made a total of 42 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 42 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 1,035 shares on September 10, 2024, which brought Stephen F. Betz around $53,303.
Insider Trading History of Stephen F. Betz
- 1
Stephen F. Betz Trading Performance
Stephen F. Betz Ownership Network
Ownership Network List of Stephen F. Betz
Ownership Network Relation of Stephen F. Betz
Stephen F. Betz Owned Company Details
What does Crinetics Pharmaceuticals Inc do?
Who are the key executives at Crinetics Pharmaceuticals Inc?
Stephen F. Betz is the Chief Scientific Officer of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Development Officer Dana Pizzuti , See Remarks Marc Wilson , and Chief Operating Officer Jeff E. Knight .
Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary
Over the past 18 months, Stephen F. Betz made 14 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 40,035. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 159,049 shares made by Marc Wilson , a net sale of 91,672 shares made by Dana Pizzuti , and a net sale of 448,399 shares made by Richard Scott Struthers .
In summary, during the past 3 months, insiders sold 46,410 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 46,410 shares. During the past 18 months, 913,970 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 908,970 shares.
Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crinetics Pharmaceuticals Inc Insider Transactions
Stephen F. Betz Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen F. Betz. You might contact Stephen F. Betz via mailing address: 10222 Barnes Canyon Road, Building 2, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
